Evaluation of detection of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella spp. isolates by VITEK 2 AST-N029 compared to the agar dilution and disk diffusion methods

References

• Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1–14
   PubMed Web of Science ®Google Scholar
• Jacoby JA, Bush K. Amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant ß-lactamases. 2006 July, 7 [cited 2006; Available from: http://www.lahey.org/Studies/.
   Google Scholar
• Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med 2005; 352: 380–91
   PubMed Web of Science ®Google Scholar
• Livermore DM, Williams JD. β-lactams: mode of action and mechanisms of bacterial resistance 5th edn, V. Lorian 1996. Baltimore: Williams & Wilkins; 1996. p. 502–78.
   Google Scholar
• Livermore DM, Brown DFJ. Detection of β-lactamase-mediated resistance. J Antimicrob Chemother 2001; 48: 59–64
   PubMed Web of Science ®Google Scholar
• Ramphal R, Ambrose PG. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis 2006; 42: S164–72
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. M7-A7, Wayne, Pa. Seventh edn. 26 2007.
   Google Scholar
• Livermore DM, Brown DFJ. Detection of β-lactamase-mediated resistance. 2005 [cited 2007 31. 3 2007].
   Google Scholar
• Clinical and Laboratory Standards Institute, Performance standards for Antimicrobial Disk Susceptibility Tests; Approved Standard, M2-A9. Wayne, PA. 9th edn. 2007.
   Google Scholar
• Jossart MF, Courcol RJ. Evaluation of an automated system for identification of Enterobacteriaceae and non-fermenting bacilli. Eur J Clin Microbiol Infect Dis 1999; 18: 902–7
   PubMed Web of Science ®Google Scholar
• Livermore DM, Struelens M, Amorim J, Baquero F, Bille J, Canton R, et al. Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother 2002; 49: 289–300
   PubMed Web of Science ®Google Scholar
• Sanders CC, Peyret M, Moland ES, Shubert C, Thomson KS, Boeufgras J-M, et al. Ability of the VITEK 2 Advanced Expert System to identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol 2000; 38: 570–4
   PubMed Web of Science ®Google Scholar
• Nyberg SD, Österblad M, Hakanen AJ, Huovinen P, Jalava J. the Finnish Study Group for Antimicrobial Resistance. Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002–2004. Scand J Infect Dis 2007; 39: 417–24
   PubMed Web of Science ®Google Scholar
• Sorlozano A, Gutierrez J, Piedrola G, Soto MJ. Acceptable performance of VITEK 2 system to detect extended-spectrum beta-lactamases in clinical isolates of Escherichia coli: a comparative study of phenotypic commercial methods and NCCLS guidelines. Diagn Microbiol Infect Dis 2005; 51: 191–3
   PubMed Web of Science ®Google Scholar
• Spanu T, Sanguinetti M, Tumbarello M, D'Inzeo T, Fiori B, Posteraro B, et al. Evaluation of the New VITEK 2 Extended-Spectrum Beta-Lactamase (ESBL) Test for rapid detection of ESBL production in Enterobacteriaceae isolates. J Clin Microbiol 2006; 44: 3257–62
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwartz D, Carmeli Y. Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp. J Clin Microbiol 2006; 44: 241–3
   PubMed Web of Science ®Google Scholar
• Dashti AA, West P, Paton R, Amyes SGB. Characterization of extended-spectrum beta-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains. J Med Microbiol 2006; 55: 417–21
   PubMed Web of Science ®Google Scholar
• Rantakokko-Jalava K, Elo-Lehtonen E, Meurman O. Comparison of workflow and accuracy of identification and antimicrobial susceptibility testing of clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and enterococci by Vitek 2 and routine methods. APMIS 2006; 114: 43–9
   PubMed Web of Science ®Google Scholar
• Ziegler R, Johnscher I, Martus P, Lenhardt D, Just HM. Controlled clinical laboratory comparison of two supplemented aerobic and anaerobic media used in automated blood culture systems to detect bloodstream infections. J Clin Microbiol 1998; 36: 657–61
   PubMed Web of Science ®Google Scholar
• Schiappa DA, Hayden MK, Matushek MG, Hashemi FN, Sullivan J, Smith KY, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiological investigation. J Infect Dis 1996; 174: 529–36
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteraemia with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006; 50: 1257–62
   PubMed Web of Science ®Google Scholar
• Andes D, Craig WA. Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations. Clin Microbiol Infect 2005; 11: 10–7
   PubMed Web of Science ®Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657–86
   PubMed Web of Science ®Google Scholar
• Potz NA, Colman M, Warner M, Reynolds R, Livermore DM. False positive extended-spectrum beta-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 β-lactamase. J Antimicrob Chemother 2004; 53: 545–7
   PubMed Web of Science ®Google Scholar
• Fournier B, Roy PH. Variability of chromosomally encoded β-lactamases from Klebsiella oxytoca. Antimicrob Agents Chemother 1997; 41: 1641–8
   PubMed Web of Science ®Google Scholar
• Hanson ND. AmpC β-lactamases: what do we need to know for the future?. J Antimicrob Chemother 2003; 52: 2–4
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Segreti J. Overview of the epidemiological profile and laboratory detection of extended-spectrum β-lactamases. Clin Infect Dis 2006; 42: S153–63
   PubMed Web of Science ®Google Scholar
• Nasim K, Elsayed S, Pitout JD, Conly J, Church DL, Gregson DB. New method for laboratory detection of AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae. J Clin Microbiol 2004; 42: 4799–802
   PubMed Web of Science ®Google Scholar